Related references
Note: Only part of the references are listed.Intrinsic blood-brain barrier dysfunction contributes to multiple sclerosis pathogenesis
Hideaki Nishihara et al.
BRAIN (2022)
Improving the Efficacy of Regulatory T Cell Therapy
Paulien Baeten et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2022)
The FOXP3 full-length isoform controls the lineage-stability of CD4+FOXP3+ regulatory T cells
Christina Seitz et al.
CLINICAL IMMUNOLOGY (2022)
Oncostatin M triggers brain inflammation by compromising blood-brain barrier integrity
Doryssa Hermans et al.
ACTA NEUROPATHOLOGICA (2022)
FOXP3 exon 2 controls Treg stability and autoimmunity
Jianguang Du et al.
SCIENCE IMMUNOLOGY (2022)
Defective CD19+CD24hiCD38hitransitional B-cell function in patients with relapsing-remitting MS
Maria T. Cencioni et al.
MULTIPLE SCLEROSIS JOURNAL (2021)
Administration of CD4+CD25highCD127-FoxP3+ Regulatory T Cells for Relapsing-Remitting Multiple Sclerosis: A Phase 1 Study
Kamil Chwojnicki et al.
BIODRUGS (2021)
Tissue-restricted control of established central nervous system autoimmunity by TNF receptor 2-expressing Treg cells
Emilie Ronin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
B cells in multiple sclerosis - from targeted depletion to immune reconstitution therapies
Maria T. Cencioni et al.
NATURE REVIEWS NEUROLOGY (2021)
CD8+ Regulatory T Cell - A Mystery to Be Revealed
Shruti Mishra et al.
FRONTIERS IN IMMUNOLOGY (2021)
The effect of low-dose IL-2 and Treg adoptive cell therapy in patients with 1 diabetes
Shen Dong et al.
JCI INSIGHT (2021)
Regulatory T cells promote remyelination in the murine experimental autoimmune encephalomyelitis model of multiple sclerosis following human neural stem cell transplant
Laura L. McIntyre et al.
NEUROBIOLOGY OF DISEASE (2020)
Regulatory T cells suppress Th17 cell Ca2+ signaling in the spinal cord during murine autoimmune neuroinflammation
Shivashankar Othy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
In Vitro Tailoring of Regulatory T Cells Prior to Cell Therapy
Paulien Baeten et al.
TRENDS IN MOLECULAR MEDICINE (2020)
Engineered regulatory T cells expressing myelin-specific chimeric antigen receptors suppress EAE progression
Alessandra De Paula Pohl et al.
CELLULAR IMMUNOLOGY (2020)
CCR6 blockade on regulatory T cells ameliorates experimental model of multiple
Izabela Jatczak-Pawlik et al.
CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY (2020)
Ozanimod to Treat Relapsing Forms of Multiple Sclerosis: A Comprehensive Review of Disease, Drug Efficacy and Side Effects
Grace Lassiter et al.
NEUROLOGY INTERNATIONAL (2020)
Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition
Clare Walton et al.
MULTIPLE SCLEROSIS JOURNAL (2020)
The proportion of peripheral regulatory T cells in patients with Multiple Sclerosis: A meta-analysis
Li Yu-Feng et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2019)
CD24hiCD38hi and CD24hiCD27+ Human Regulatory B Cells Display Common and Distinct Functional Characteristics
Md Mahmudul Hasan et al.
JOURNAL OF IMMUNOLOGY (2019)
Adoptive Transfer of Regulatory T Cells as a Promising Immunotherapy for the Treatment of Multiple Sclerosis
Samuel S. Duffy et al.
FRONTIERS IN NEUROSCIENCE (2019)
Brain regulatory T cells suppress astrogliosis and potentiate neurological recovery
Minako Ito et al.
NATURE (2019)
Pathogenic Mechanisms Associated With Different Clinical Courses of Multiple Sclerosis
Hans Lassmann
FRONTIERS IN IMMUNOLOGY (2019)
T helper 17.1 cells associate with multiple sclerosis disease activity: perspectives for early intervention
Jamie van Langelaar et al.
BRAIN (2018)
Signaling via toll-like receptor 4 and CD40 in B cells plays a regulatory role in the pathogenesis of multiple sclerosis through interleukin-10 production
Yoichiro Okada et al.
JOURNAL OF AUTOIMMUNITY (2018)
FoxP3 isoforms and PD-1 expression by T regulatory cells in multiple sclerosis
Manolo Sambucci et al.
SCIENTIFIC REPORTS (2018)
Characterization of a murine mixed neuron-glia model and cellular responses to regulatory T cell-derived factors
Marie Dittmer et al.
MOLECULAR BRAIN (2018)
Memory B Cells Activate Brain-Homing, Autoreactive CD4+ T Cells in Multiple Sclerosis
Ivan Jelcic et al.
CELL (2018)
Multiple sclerosis: experimental models and reality
Hans Lassmann et al.
ACTA NEUROPATHOLOGICA (2017)
Role of Mast Cells in the Pathogenesis of Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
Daniel Elieh-Ali-Komi et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2017)
Regulatory T cells in multiple sclerosis and myasthenia gravis
K. M. Danikowski et al.
JOURNAL OF NEUROINFLAMMATION (2017)
Regulatory T cells promote myelin regeneration in the central nervous system
Yvonne Dombrowski et al.
NATURE NEUROSCIENCE (2017)
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
S. L. Hauser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
X. Montalban et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
CCR8+FOXp3+ Treg cells as master drivers of immune regulation
Yiftah Barsheshet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Umbilical cord blood-derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect
Claudio G. Brunstein et al.
BLOOD (2016)
Interleukin-17-and interleukin-22-secreting myelin-specific CD4+ T cells resistant to corticoids are related with active brain lesions in multiple sclerosis patients
Ana Cristina Wing et al.
IMMUNOLOGY (2016)
Immune cell trafficking across the barriers of the central nervous system in multiple sclerosis and stroke
Melissa A. Lopes Pinheiro et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2016)
Multiple sclerosis, a treatable disease
A. Doshi et al.
CLINICAL MEDICINE (2016)
Remyelination Is Correlated with Regulatory T Cell Induction Following Human Embryoid Body-Derived Neural Precursor Cell Transplantation in a Viral Model of Multiple Sclerosis
Warren C. Plaisted et al.
PLOS ONE (2016)
Adoptive transfer of allogeneic regulatory T cells into patients with chronic graft-versus-host disease
Anke Theil et al.
CYTOTHERAPY (2015)
Cell surface levels of endothelial ICAM-1 influence the transcellular or paracellular T-cell diapedesis across the blood-brain barrier
Michael Abadier et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2015)
Interleukin-22 is increased in multiple sclerosis patients and targets astrocytes
Guillaume Perriard et al.
JOURNAL OF NEUROINFLAMMATION (2015)
Glycolysis controls the induction of human regulatory T cells by modulating the expression of FOXP3 exon 2 splicing variants
Veronica De Rosa et al.
NATURE IMMUNOLOGY (2015)
Type 1 diabetes immunotherapy using polyclonal regulatory T cells
Jeffrey A. Bluestone et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Glial regulation of the blood-brain barrier in health and disease
Bieke Broux et al.
SEMINARS IN IMMUNOPATHOLOGY (2015)
Activated regulatory T cell regulates neural stem cell proliferation in the subventricular zone of normal and ischemic mouse brain through interleukin 10
Jixian Wang et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2015)
Integrin alpha L controls the homing of regulatory T cells during CNS autoimmunity in the absence of integrin alpha 4
Simon Glatigny et al.
SCIENTIFIC REPORTS (2015)
An update on immunopathogenesis, diagnosis, and treatment of multiple sclerosis
Neeta Garg et al.
BRAIN AND BEHAVIOR (2015)
Treatment strategies for multiple sclerosis: When to start, when to change, when to stop?
Alberto Gajofatto et al.
WORLD JOURNAL OF CLINICAL CASES (2015)
T cell mediated pathogenesis in EAE: Molecular mechanisms
Florian C. Kurschus
BIOMEDICAL JOURNAL (2015)
Immunopathology of multiple sclerosis
Calliope A. Dendrou et al.
NATURE REVIEWS IMMUNOLOGY (2015)
TLR-2 Signaling Promotes IL-17A Production in CD4+CD25+Foxp3+ Regulatory Cells during Oropharyngeal Candidiasis
Natarajan Bhaskaran et al.
PATHOGENS (2015)
Role of the Blood-Brain Barrier in Multiple Sclerosis
Genaro Gabriel Ortiz et al.
ARCHIVES OF MEDICAL RESEARCH (2014)
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse
Massimo F. Martelli et al.
BLOOD (2014)
Pathogenic conversion of Foxp3(+) T cells into T(H)17 cells in autoimmune arthritis
Noriko Komatsu et al.
NATURE MEDICINE (2014)
Interleukin-34 Restores Blood-Brain Barrier Integrity by Upregulating Tight Junction Proteins in Endothelial Cells
Shijie Jin et al.
PLOS ONE (2014)
Abnormal blood-brain barrier permeability in normal appearing white matter in multiple sclerosis investigated by MRI
S. P. Cramer et al.
NEUROIMAGE-CLINICAL (2014)
Treg cells mediate recovery from EAE by controlling effector T cell proliferation and motility in the CNS
Michail Koutrolos et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2014)
CC chemokine receptor 8 potentiates donor Treg survival and is critical for the prevention of murine graft-versus-host disease
James M. Coghill et al.
BLOOD (2013)
Self-antigen-Driven Activation Induces Instability of Regulatory T Cells during an Inflammatory Autoimmune Response
Samantha L. Bailey-Bucktrout et al.
IMMUNITY (2013)
Is MS an inflammatory or primary degenerative disease?
Jacek Losy
JOURNAL OF NEURAL TRANSMISSION (2013)
Anti-CD40 Ab- or 8-oxo-dG-enhanced Treg cells reduce development of experimental autoimmune encephalomyelitis via down-regulating migration and activation of mast cells
Gwan Ui Hong et al.
JOURNAL OF NEUROIMMUNOLOGY (2013)
Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status
Daphne Y. S. Vogel et al.
JOURNAL OF NEUROINFLAMMATION (2013)
Safety and Efficacy of Antigen-Specific Regulatory T-Cell Therapy for Patients With Refractory Crohn's Disease
Pierre Desreumaux et al.
GASTROENTEROLOGY (2012)
Animal models of multiple sclerosis: the good, the bad and the bottom line
Richard M. Ransohoff
NATURE NEUROSCIENCE (2012)
Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)
Cris S. Constantinescu et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Reduction in IL-10 producing B cells (Breg) in multiple sclerosis is accompanied by a reduced naive/memory Breg ratio during a relapse but not in remission
Stephanie Knippenberg et al.
JOURNAL OF NEUROIMMUNOLOGY (2011)
Identification of T helper type 1-like, Foxp3+ regulatory T cells in human autoimmune disease
Margarita Dominguez-Villar et al.
NATURE MEDICINE (2011)
Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool
Bahareh Ajami et al.
NATURE NEUROSCIENCE (2011)
Intracerebral Human Regulatory T Cells: Analysis of CD4+CD25+FOXP3+ T Cells in Brain Lesions and Cerebrospinal Fluid of Multiple Sclerosis Patients
Benedikt Fritzsching et al.
PLOS ONE (2011)
Increase in Th17 and T-reg Lymphocytes and Decrease of IL22 Correlate with the Recovery Phase of Acute EAE IN Rat
Beatriz Almolda et al.
PLOS ONE (2011)
Fluids and barriers of the CNS establish immune privilege by confining immune surveillance to a two-walled castle moat surrounding the CNS castle
Britta Engelhardt et al.
FLUIDS AND BARRIERS OF THE CNS (2011)
Abnormal B-Cell Cytokine Responses A Trigger of T-Cell Mediated Disease in MS?
Amit Bar-Or et al.
ANNALS OF NEUROLOGY (2010)
Th17/Th1 phenotype in demyelinating disease
L. J. Edwards et al.
CYTOKINE (2010)
Reduced Treg frequency in LFA-1-deficient mice allows enhanced T effector differentiation and pathology in EAE
Sandra Gueltner et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
Regulatory T cells exhibit enhanced migratory characteristics, a feature impaired in patients with multiple sclerosis
Tilman Schneider-Hohendorf et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
Differential Roles for Endothelial ICAM-1, ICAM-2, and VCAM-1 in Shear-Resistant T Cell Arrest, Polarization, and Directed Crawling on Blood-Brain Barrier Endothelium
Oliver Steiner et al.
JOURNAL OF IMMUNOLOGY (2010)
Blood-brain barrier disruption and enhanced vascular permeability in the multiple sclerosis model EAE
Jami Bennett et al.
JOURNAL OF NEUROIMMUNOLOGY (2010)
Glucocorticoid effects on endothelial barrier function in the murine brain endothelial cell line cEND incubated with sera from patients with multiple sclerosis
Kinga G. Blecharz et al.
MULTIPLE SCLEROSIS JOURNAL (2010)
Temporal Pattern of ICAM-I Mediated Regulatory T Cell Recruitment to Sites of Inflammation in Adoptive Transfer Model of Multiple Sclerosis
Sebastian Doerck et al.
PLOS ONE (2010)
Preferential Recruitment of Interferon-γ-Expressing TH17 Cells in Multiple Sclerosis
Hania Kebir et al.
ANNALS OF NEUROLOGY (2009)
CD49d provides access to untouched human Foxp3+ Treg free of contaminating effector cells
Markus Kleinewietfeld et al.
BLOOD (2009)
Oligoclonal myelin-reactive T-cell infiltrates derived from multiple sclerosis lesions are enriched in Th17 cells
Monica Montes et al.
CLINICAL IMMUNOLOGY (2009)
First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127-T regulatory cells
Piotr Trzonkowski et al.
CLINICAL IMMUNOLOGY (2009)
CCR6 regulates EAE pathogenesis by controlling regulatory CD4(+) T-cell recruitment to target tissues
Ricardo Villares et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from TH-17, TH1 and TH2 cells
Sara Trifari et al.
NATURE IMMUNOLOGY (2009)
Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells
Thomas Duhen et al.
NATURE IMMUNOLOGY (2009)
The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation
Meghan A. Koch et al.
NATURE IMMUNOLOGY (2009)
CD4+ Regulatory T Cells Control TH17 Responses in a Stat3-Dependent Manner
Ashutosh Chaudhry et al.
SCIENCE (2009)
Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis
John S. Tzartos et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Compromised CD4(+) CD25(high) regulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell level
Koen Venken et al.
IMMUNOLOGY (2008)
Multiple Sclerosis and Regulatory T Cells
Cristina Maria Costantino et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2008)
CCR6 Regulates the Migration of Inflammatory and Regulatory T Cells
Tomohide Yamazaki et al.
JOURNAL OF IMMUNOLOGY (2008)
Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation
Hania Kebir et al.
NATURE MEDICINE (2007)
CXCR3 signaling reduces the severity of experimental autoimmune encephalomyelitis by controlling the parenchymal distribution of effector and regulatory T cells in the central nervous system
Marcus Mueller et al.
JOURNAL OF IMMUNOLOGY (2007)
Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis
Martin Duddy et al.
JOURNAL OF IMMUNOLOGY (2007)
Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation
Thomas Korn et al.
NATURE MEDICINE (2007)
IL-2 is essential for TGF-β to convert naive CD4+CD25- cells to CD25+Foxp3+ regulatory T cells and for expansion of these cells
Song Guo Zheng et al.
JOURNAL OF IMMUNOLOGY (2007)
Increased frequency of CD4(+) CD25(+) regulatory T cells in the cerebrospinal fluid but not in the blood of multiple sclerosis patients
U. Feger et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2007)
FoxP3(+) T cells undergo conventional first switch to lymphoid tissue homing receptors in thymus but accelerated second switch to nonlymphoid tissue homing receptors in secondary lymphoid tissues
Jee H. Lee et al.
JOURNAL OF IMMUNOLOGY (2007)
CD4+CD25+FoxP3+ T lymphocytes fail to suppress myelin basic protein-induced proliferation in patients with multiple sclerosis
Manoj Kumar et al.
JOURNAL OF NEUROIMMUNOLOGY (2006)
Polyclonal expansion of regulatory T cells interferes with effector cell migration in a model of multiple sclerosis
Denise Tischner et al.
BRAIN (2006)
Epithelial inflammation is associated with CCL28 production and the recruitment of regulatory T cells expressing CCR10
Bertus Eksteen et al.
JOURNAL OF IMMUNOLOGY (2006)
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis
CH Polman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Chemotactic responses of IL-4-, IL-10-, and IFN-gamma-producing CD4(+) T cells depend on tissue origin and microbial stimulus
GF Debes et al.
JOURNAL OF IMMUNOLOGY (2006)
Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis
J Haas et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
Natural recovery and protection from autoimmune encephalomyelitis:: Contribution of CD4+CD25+ regulatory cells within the central nervous system
MJ McGeachy et al.
JOURNAL OF IMMUNOLOGY (2005)
Selective targeting of regulatory T cells with CD28 superagonists allows effective therapy of experimental autoimmune encephalomyelitis
N Beyersdorf et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
CCR6 expression defines regulatory effector/memory-like cells within the CD25+CD4+ T-cell subset
M Kleinewietfeld et al.
BLOOD (2005)
Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells
MK Levings et al.
BLOOD (2005)
Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis
V Viglietta et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
The CD4-Thl model for multiple sclerosis: a crucial re-appraisal
H Lassmann et al.
TRENDS IN IMMUNOLOGY (2004)
Erratum: The CD4-Th1 model for multiple sclerosis: a crucial re-appraisal (vol 25, pg 132, 2004)
H Lassmann et al.
TRENDS IN IMMUNOLOGY (2004)
Dual effect of CD4+CD25+ regulatory T cells in neurodegeneration:: A dialogue with microglia
J Kipnis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Continuous activation of autoreactive CD4+ CD25+ regulatory T cells in the steady state
S Fisson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
A controlled trial of natalizumab for relapsing multiple sclerosis.
DH Miller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
T-cells in the cerebrospinal fluid express a similar repertoire of inflammatory chemokine receptors in the absence or presence of CNS inflammation:: implications for CNS trafficking
P Kivisäkk et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2002)
Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis
C Lock et al.
NATURE MEDICINE (2002)
Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4+CD25+ regulatory T cells
A Iellem et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Share Paper
